IP Verse

Glaxosmithkline Intellectual competitive analysis

Latest oppositions filed by Glaxosmithkline Intellectual

Explore patent oppositions filed by Glaxosmithkline Intellectual against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
EP3653221
Anti-Pvrig Antibodies And Methods Of UseCOMPUGENMay 2, 2023
EP3259597
Pvrig Polypeptides And Methods Of TreatmentCOMPUGENJan 5, 2023
EP2997036
Purification Of Recombinantly Produced PolypeptidesMEDIMMUNEDec 3, 2021
EP3616720
Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITYNov 17, 2021
EP3137186
Methods For The Purification Of Proteins Using Caprylic AcidNOVO NORDISKOct 26, 2021
EP3377618
Buffers For Stabilization Of Lentiviral PreparationsNOVARTISAug 12, 2021
EP3294770
Therapeutic And Diagnostic Methods For CancerF HOFFMANN LA ROCHEJul 7, 2021
EP3134095
Improved Methods For Manufacturing Adoptive Cell TherapiesBLUEBIRD BIOJan 21, 2021
EP3303632
Therapeutic And Diagnostic Methods For CancerF HOFFMANN LA ROCHEDec 4, 2020
EP3431105
Medicinal Composition For Treating CancerOSAKA UNIVERSITYSep 30, 2020

Latest patents of Glaxosmithkline Intellectual opposed by its competitors

Explore Glaxosmithkline Intellectual's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 25, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3682884
Apr 24, 2024Crystal Form Of Gsk1278863 And Preparation Method And Pharmaceutical Use Thereof1
EP3650019
Oct 11, 2023Fluticasone Furoate In The Treatment Of Copd4
EP3297605
May 4, 2022Topical Pharmaceutical Compositions1
EP3461474
Nov 11, 2020Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same5
EP3481838
Aug 19, 2020Novel Processes For The Production Of Oligonucleotides2
EP2654736
Jul 1, 2020Novel Pharmaceutical Composition3
EP3148521
Dec 18, 2019Fluticasone Furoate In The Treatment Of Copd3
EP2969098
Oct 30, 2019Methods For Purifying Antibodies1
EP2611422
Oct 31, 2018Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same4

Latest PTAB cases involving Glaxosmithkline Intellectual

Discover the latest PTAB cases involving Glaxosmithkline Intellectual, highlighting their recent legal challenges and patent disputes.

Last updated on: Jun 30, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Glaxosmithkline Intellectual

IPR2020-01577Sep 4, 2020EPIZYMEGLAXOSMITHKLINETerminated-Settled
IPR2020-00327Dec 19, 2019EPIZYMEGLAXOSMITHKLINEFinal Written Decision
IPR2020-00328Dec 19, 2019EPIZYMEGLAXOSMITHKLINEFinal Written Decision
IPR2016-01315Jun 30, 2016GLAXOSMITHKLINEFIBROGENInstitution Denied
IPR2016-01318Jun 30, 2016GLAXOSMITHKLINEFIBROGENInstitution Denied
IPR2016-01319Jun 30, 2016GLAXOSMITHKLINEFIBROGENInstitution Denied
IPR2016-01320Jun 30, 2016GLAXOSMITHKLINEFIBROGENInstitution Denied
IPR2016-01322Jun 30, 2016GLAXOSMITHKLINEFIBROGENInstitution Denied
IPR2016-01323Jun 30, 2016GLAXOSMITHKLINEFIBROGENInstitution Denied

Peer Comparison New

IP litigation analysis comparing Glaxosmithkline Intellectual with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLAXOSMITHKLINE2912863
FIBROGEN122 - 6
SANDOZ1261719 -
TEVA PHARMACEUTICALS218191712